TEMPLE PHARMACY LIMITEDActive

Company number 01010652Private limited companyIncorporated 1971

Key figures

£189,112-79.7%
Net assets 2024/25
-44.7%
Average annual change 2020/21–2024/25
0500 k1 m1.5 m2020/212021/222023/242024/25

Like most small UK companies, TEMPLE PHARMACY LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2024/25
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
01 m2 m2020/212021/222023/242024/25

Dividends

from the accounts
2021/22

Dividends paid in the financial year: £2,000.

History
2021/22£2,000
2020/21£2,000
Filed accounts2020/21–2024/25
2020/212021/222023/242024/25
Profit for the year-34,815-345,339——
Cash at bank and in hand275,072257,68999,839—
Total assets1,801,0691,214,5061,319,910563,300
Total liabilities————
Net assets / total equity1,120,620773,281933,017189,112
Average number of employees27252017
Dividends paid2,0002,000——

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: TEMPLE PHARMACY LIMITED

Company

TEMPLE PHARMACY LIMITED is a private limited company registered with Companies House under company number 01010652. It was incorporated on 10 May 1971. Its status is active. The registered office is in London (W1T). Its nature of business (SIC 2007) is dispensing chemist in specialised stores (47730).

Accounts

The latest accounts in the database are for 2024/25 (period ending 30 Apr 2025); the company files small company accounts (filleted). Net assets were £189,112, down 79.7% on the previous year. The company had an average of 17 employees. Figures are available for 4 financial years (2020/21–2024/25).

Control and charges

One person with significant control is registered. 1 of 25 registered charges are outstanding.

Filing deadlines

The next accounts are due by 31 Jan 2027. The next confirmation statement is due by 15 Apr 2027.